CD8A and neoplasm: In addition to chronic antigen exposure and hypoxia at the tumor, receptor-ligand interactions between myeloid cells and CD8+ T cells can promote an environment where impaired T cell function, termed T cell exhaustion (6–9), limits patient immunotherapeutic response (10–12).